- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00315913
Trial of Oxytocin Alone Versus Oxytocin and Propranolol for the Treatment of Abnormal Labor
February 26, 2019 updated by: Deborah A. Wing, University of California, Irvine
Placebo-Controlled Randomized Trial of Oxytocin Alone Versus Oxytocin and Propranolol for the Treatment of Dysfunctional Labor
The purpose of this study is to determine whether propranolol is better than oxytocin for the treatment of labor abnormalities.
The endpoint is the rate of vaginal delivery experienced by women receiving prolonged oxytocin versus propranolol.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
This trial was designed to test if propranolo can reduce the c section rate for dysfuctional labor.
Due to stringent inclution and exclusion criteria and low enrollment the study was closed.
Study Type
Interventional
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Long Beach, California, United States, 90806
- Long Beach Memorial Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Must be term pregnancy (> 37 weeks)
- Vertex presentation
- Active labor (4-5 centimeters dilated)
Exclusion Criteria:
- Heart disease
- Diabetes
- Currently taking propranolol
- Contraindications to labor or vaginal delivery
- Multiple gestations
- Preterm
- Chorioamnionitis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: IV Propranolol
IV dose propranolol
|
IV Propranolol 1mg/min for a total of 2 minutes.
Total dose 2mg
Other Names:
|
|
Placebo Comparator: IV Placebo
IV Placebo of saline solution equal to propranolol in volume
|
IV Saline Solution
Other Names:
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Leah R Battista, MD, University of California, Irvine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2004
Primary Completion (Actual)
March 1, 2008
Study Completion (Actual)
March 1, 2008
Study Registration Dates
First Submitted
April 17, 2006
First Submitted That Met QC Criteria
April 17, 2006
First Posted (Estimate)
April 19, 2006
Study Record Updates
Last Update Posted (Actual)
February 27, 2019
Last Update Submitted That Met QC Criteria
February 26, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pregnancy Complications
- Obstetric Labor Complications
- Dystocia
- Physiological Effects of Drugs
- Adrenergic beta-Antagonists
- Adrenergic Antagonists
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Antihypertensive Agents
- Vasodilator Agents
- Propranolol
Other Study ID Numbers
- HS #2004-3997
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dysfunctional Labor
-
Genentech, Inc.CompletedDysfunctional Hemodialysis Catheters
-
University of Colorado, DenverNot yet recruitingDysfunctional VoidingUnited States
-
Halic UniversityCompleted
-
Buddhist Tzu Chi General HospitalCompleted
-
Tanta UniversityRecruitingChildren | Biofeedback | Dysfunctional Voiding | Medical TreatmentEgypt
-
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training...Active, not recruitingDysfunctional Voiding | Biofeedback Therapy | Giggle IncontinenceTurkey (Türkiye)
-
Genentech, Inc.CompletedDysfunctional Central Venous Access Devices (CVADS)
-
Pamukkale UniversityNot yet recruitingDysfunctional Breathing | Breathing Patterns
-
Baylor Research InstituteTerminatedBlood Loss | Uterine Atony | Dysfunctional Labor
-
Medtronic CardiovascularCompletedDysfunctional Right Ventricular Outflow Tract (RVOT) ConduitUnited States
Clinical Trials on Propranolol
-
Cairo UniversityCompleted
-
University of UtahTerminated
-
University Hospital, GenevaSuspendedStage IB Skin Melanoma | Stages III Skin Melanoma | Stages II Skin MelanomaSwitzerland
-
Mela, Mansfield, M.D.UnknownPosttraumatic Stress Disorder | Traumatic MemoryCanada
-
Tang-Du HospitalNot yet recruitingIntracerebral Hemorrhage | Stroke-Associated Pneumonia (SAP)China
-
Douglas Mental Health University InstituteInstitut de Recherche Robert-Sauvé en Santé et en Sécurité du TravailRecruitingTrauma and Stressor Related Disorders | Post-traumatic Stress Disorders | Adjustment Disorders | Acute Stress DisorderCanada
-
Taipei Veterans General Hospital, TaiwanUnknownCirrhosis | Acute Kidney Injury | Esophageal VaricesTaiwan
-
Bloom Mental Health, LLCRecruiting
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Completed
-
Vanderbilt UniversityCompleted